nccn-breast-cancer

name	nccn-breast-cancer
description	NCCN clinical practice guideline navigation for Breast Cancer. Use when a clinician needs treatment decisions, staging, workup, or evidence for Breast Cancer based on NCCN Guidelines version 2.2026.
metadata	{"author":"nccn-skill-generator","version":"2.2026","source":"NCCN Clinical Practice Guidelines in Oncology","guideline":"Breast Cancer"}
license	See NCCN terms of use

NCCN Guidelines: Breast Cancer

Clinical decision support derived from NCCN Clinical Practice Guidelines in Oncology. Version 2.2026.

Disease Subtypes

Special Considerations for Breast Cancer in Men

• Algorithm: Special Considerations for Breast Cancer in Men -- Staging, workup, and treatment pathways

Adjuvant Endocrine Therapy

• Algorithm: Adjuvant Endocrine Therapy -- Staging, workup, and treatment pathways

Gene Expression Assays for Consideration of Addition of Adjuvant Systemic Systemic Therapy

• Algorithm: Gene Expression Assays for Consideration of Addition of Adjuvant Systemic Systemic Therapy -- Staging, workup, and treatment pathways

Definition of Menopause

• Algorithm: Definition of Menopause -- Staging, workup, and treatment pathways

Systemic Therapy Regimens for Recurrent Unresectable or Stage IV (M1) Disease

• Algorithm: Systemic Therapy Regimens for Recurrent Unresectable or Stage IV (M1) Disease -- Staging, workup, and treatment pathways

Additional Targeted Therapies and Associated Biomarker Testing for Recurrent or Stage IV

• Algorithm: Additional Targeted Therapies and Associated Biomarker Testing for Recurrent or Stage IV -- Staging, workup, and treatment pathways

Phyllodes Tumor

• Algorithm: Phyllodes Tumor -- Staging, workup, and treatment pathways

Paget’s Disease

• Algorithm: Paget’s Disease -- Staging, workup, and treatment pathways

Inflammatory Breast Cancer

• Algorithm: Inflammatory Breast Cancer -- Staging, workup, and treatment pathways

Ductal Carcinoma in Situ (Tis, N0, M0)

• Evidence: Ductal Carcinoma in Situ (Tis, N0, M0) -- Discussion of clinical evidence and rationale

Invasive Breast Cancer

• Evidence: Invasive Breast Cancer -- Discussion of clinical evidence and rationale

Breast Reconstruction

• Evidence: Breast Reconstruction -- Discussion of clinical evidence and rationale

Systemic Therapies (Preoperative and Adjuvant)

• Evidence: Systemic Therapies (Preoperative and Adjuvant) -- Discussion of clinical evidence and rationale

Post-Therapy Surveillance and Follow-up for T0–3, N1, M0 and T1–3, N0–1, M0 Tumors

• Evidence: Post-Therapy Surveillance and Follow-up for T0–3, N1, M0 and T1–3, N0–1, M0 Tumors -- Discussion of clinical evidence and rationale

Recurrent/Stage IV Breast Cancer

• Evidence: Recurrent/Stage IV Breast Cancer -- Discussion of clinical evidence and rationale

Special Situations

• Evidence: Special Situations -- Discussion of clinical evidence and rationale

Summary

• Evidence: Summary -- Discussion of clinical evidence and rationale

Special Populations

Breast Cancer During Pregnancy

• Algorithm: Breast Cancer During Pregnancy -- Staging, workup, and treatment pathways

Shared Resources

Principles of Preoperative Systemic Therapy

• Principles of Preoperative Systemic Therapy -- General treatment principles

Principles of Monitoring Metastatic Disease

• Principles of Monitoring Metastatic Disease -- General treatment principles

Staging

• Staging -- Staging classification

Overview

• Overview -- Shared clinical resource

Sensitive/Inclusive Language Usage

• Sensitive/Inclusive Language Usage (Evidence) -- Shared clinical resource

Guidelines Update Methodology

• Guidelines Update Methodology (Evidence) -- Shared clinical resource

---

Citation: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 2.2026. National Comprehensive Cancer Network. Available at nccn.org.

This skill references copyrighted NCCN content. Refer to nccn.org for the authoritative source and full terms of use.